U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from Nucleotide

Pseudomonas aeruginosa resistant to imipenem/relebactam: CLB 24388

Identifiers
BioSample: SAMN17616831; Sample name: CLB24388; SRA: SRS8171306
Organism
Pseudomonas aeruginosa
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas; Pseudomonas aeruginosa group
Package
Pathogen: clinical or host-associated; version 1.0
Attributes
strainCLB 24388
collection date2004
broad-scale environmental contextmissing
local-scale environmental contextmissing
environmental mediummissing
geographic locationUSA: Texas
hostHomo sapiens
isolation and growth conditionmissing
latitude and longitude31.9686 N 99.9018 W
number of repliconsmissing
reference for biomaterialmissing
isolation sourceurine
collected bymissing
host diseasemissing
Specimen Collector's InstitutionEurofins (Lancaster, PA)
Specimen RepositoryEurofins (Lancaster, PA)
Sample Provider Principle Investigator (PI) NameRobert A. Bonomo
Sample Provider PI's InstitutionLouis Stokes Cleveland Veterans Affairs Medical Center
Sample Provider PI's email[email protected]
Description

Investigation into the mechanism of resistance of Pseudomonas aeruginosa clinical isolates to diazabicyclooctane (DBO) inhibitor relebactam (REL) in combination with imipenem (IMI).

BioProject
PRJNA342804 Pseudomonas aeruginosa
Retrieve all samples from this project

Submission
J. Craig Venter Institute, Derrick Fouts; 2021-01-28
Antibiogram
AntibioticResistance phenotypeMeasurement signMeasurementMeasurement unitsLaboratory typing methodLaboratory typing platformVendorLaboratory typing method version or reagentTesting standard
amikacinresistant>32mg/LMICMicroscanBeckman Coulter IncCLSI
aztreonamresistant>16mg/LMICMicroscanBeckman Coulter IncCLSI
cefepimeresistant>16mg/LMICMicroscanBeckman Coulter IncCLSI
cefotaximenot defined>32mg/LMICMicroscanBeckman Coulter IncCLSI
ceftazidimeresistant>16mg/LMICMicroscanBeckman Coulter IncCLSI
ciprofloxacinresistant>2mg/LMICMicroscanBeckman Coulter IncCLSI
meropenemresistant>8mg/LMICMicroscanBeckman Coulter IncCLSI
levofloxacinresistant>4mg/LMICMicroscanBeckman Coulter IncCLSI
gentamicinresistant>8mg/LMICMicroscanBeckman Coulter IncCLSI
piperacillin-tazobactamresistant>64/4mg/LMICMicroscanBeckman Coulter IncCLSI
tobramycinresistant>8mg/LMICMicroscanBeckman Coulter IncCLSI
imipenemresistant==32mg/LMICcation adjusted Mueller-Hinton (MH) agar dilutionCLSI
ceftazidime-avibactamintermediate==16/4mg/LMICLiofilchem Inc.MIC Test StripCLSI
meropenem-vaborbactamresistant==32/8mg/LMICLiofilchem Inc.MIC Test StripCLSI
ceftolozane-tazobactamresistant==64/4mg/LMICLiofilchem Inc.MIC Test StripCLSI
colistinintermediate==2mg/LMICBiomérieuxE-TestCLSI
imipenem-relebactamresistant==8/4mg/LMICcation adjusted Mueller-Hinton (MH) agar dilutionmissing
Accession:
SAMN17616831
ID:
17616831

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center